BioScrip (BIOS) Misses Q4 EPS by 70c

BioScrip (NASDAQ: BIOS) reported Q4 EPS of ($0.69), $0.70 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $253.7 million versus the consensus estimate of $259.62 million.

For earnings history and earnings-related data on BioScrip (BIOS) click here.

You May Also Be Interested In

• Super Micro Computer (SMCI) Falls 6%
• Lakeland Bancorp (LBAI) Tops Q1 EPS by 1c
• Fifth Third Bancorp (FITB) Tops Q1 EPS by 2c